'Omics' biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study.
about
Validation of standard operating procedures in a multicenter retrospective study to identify -omics biomarkers for chronic low back pain.What is the future of pharmacogenomics in pain management?CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort
P2860
'Omics' biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
'Omics' biomarkers associated ...... rospective longitudinal study.
@en
'Omics' biomarkers associated ...... rospective longitudinal study.
@nl
type
label
'Omics' biomarkers associated ...... rospective longitudinal study.
@en
'Omics' biomarkers associated ...... rospective longitudinal study.
@nl
prefLabel
'Omics' biomarkers associated ...... rospective longitudinal study.
@en
'Omics' biomarkers associated ...... rospective longitudinal study.
@nl
P2093
P2860
P50
P1433
P1476
'Omics' biomarkers associated ...... trospective longitudinal study
@en
P2093
Andrea Skelin
Christian Gieger
Dragan Primorac
Guido Fanelli
Iain K Pemberton
Ivan Gudelj
Jan Van Zundert
Jane MacDougall
Judith Manz
Klaas Buyse
P2860
P304
P356
10.1136/BMJOPEN-2016-012070
P50
P577
2016-10-19T00:00:00Z